Understanding of the Site-Specific Microbial Patterns towards Accurate Identification for Patients with Diarrhea-Predominant Irritable Bowel Syndrome Original paper
-
Irritable Bowel Syndrome (IBS)
Irritable Bowel Syndrome (IBS)
Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder characterized by symptoms such as abdominal pain, bloating, and altered bowel habits. Recent research has focused on the gut microbiota's role in IBS, aiming to identify specific microbial signatures associated with the condition.
-
Kimberly Eyer
Kimberly Eyer, a Registered Nurse with 30 years of nursing experience across diverse settings, including Home Health, ICU, Operating Room Nursing, and Research. Her roles have encompassed Operating Room Nurse, RN First Assistant, and Acting Director of a Same Day Surgery Center. Her specialty areas include Adult Cardiac Surgery, Congenital Cardiac Surgery, Vascular Surgery, and Neurosurgery.
Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.
Karen Pendergrass
Location
China
Sample Site
Duodenal mucosa
Lumen of duodenum
Mucosa of rectum
Rectal lumen
Species
Homo sapiens
What Was Studied?
This study focused on understanding the site-specific microbial patterns within the intestinal tract of patients with diarrhea-predominant irritable bowel syndrome (IBS-D). Unlike traditional studies that primarily use fecal samples, this research employed a multi-site sampling strategy to analyze microbial communities at the duodenal mucosa (DM), duodenal lumen (DL), rectal mucosa (RM), and rectal lumen (RL) of IBS-D patients and healthy controls. The primary objective was to identify microbial biomarkers and site-specific microbial signatures that could enhance diagnostic accuracy for IBS-D.
Who Was Studied?
The study included 74 IBS-D patients and 20 healthy controls. A total of 283 samples were collected from four distinct intestinal sites (DM, DL, RM, RL), allowing for a comprehensive evaluation of microbial composition and diversity along the gastrointestinal tract. This site-specific sampling enabled the detection of unique microbial biomarkers that are potentially indicative of IBS-D pathology.
What Were the Most Important Findings?
The study revealed substantial microbial dysbiosis in IBS-D patients, characterized by site-specific microbial alterations that were not evident in healthy controls. In the duodenum, IBS-D patients exhibited higher abundances of Pseudomonas, Streptococcus, and Acinetobacter, whereas Burkholderia and Bacillus were dominant in healthy subjects. Rectal mucosa (RM) samples from IBS-D patients were particularly enriched with Bacteroides, Prevotella, and Oscillospira, which served as potential biomarkers for IBS-D. Notably, these site-specific microbial shifts were associated with symptom severity, including abdominal pain and bloating. The rectal mucosa community (RM) demonstrated a high predictive power for distinguishing IBS-D from healthy controls, with a Random Forest model achieving an AUC of 97.36%. Additionally, the co-abundance network analysis revealed decreased microbial connectivity in IBS-D patients, suggesting a loss of beneficial microbial interactions. The study concluded that rectal mucosa sampling is more diagnostically valuable than fecal samples for identifying IBS-D-specific microbial dysbiosis. This indicates that traditional fecal sampling may not adequately capture the microbial changes occurring within specific gut niches of IBS-D patients.
| Intestinal Site | Microbial Findings in IBS-D Patients |
|---|---|
| Duodenal Mucosa (DM) | Increased abundances of Pseudomonas, Streptococcus, and Acinetobacter. Reduced levels of Burkholderia and Bacillus compared to healthy controls. |
| Duodenal Lumen (DL) | Elevated levels of Enterococcus and Streptococcus, indicating localized dysbiosis in the small intestine. |
| Rectal Mucosa (RM) | Significant enrichment of Bacteroides, Prevotella, and Oscillospira, identified as potential biomarkers for IBS-D. |
| Rectal Lumen (RL) | Altered community structure with increases in pathogenic genera like Fusobacterium and reductions in Faecalibacterium. |
| Microbial Connectivity | Decreased co-abundance network connections, suggesting disrupted microbial interactions in IBS-D patients. |
| Diagnostic Value | Rectal mucosa samples showed high predictive power for IBS-D diagnosis with an AUC of 97.36% in Random Forest models. |
What Are the Greatest Implications of This Study?
The findings of this study underscore the critical importance of site-specific microbial sampling for the accurate diagnosis and characterization of IBS-D. The discovery of RM-specific biomarkers (Bacteroides, Prevotella, Oscillospira) suggests that diagnostic approaches could be significantly enhanced by targeting microbial signatures from the rectal mucosa rather than relying solely on fecal samples. This site-specific understanding opens the door for more precise microbiome-based diagnostics and targeted therapeutic strategies. The study also emphasizes the need for personalized medicine approaches that consider regional microbiota variability along the gastrointestinal tract, which could lead to better symptom management and improved patient outcomes.
Irritable Bowel Syndrome (IBS)
Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder characterized by symptoms such as abdominal pain, bloating, and altered bowel habits. Recent research has focused on the gut microbiota's role in IBS, aiming to identify specific microbial signatures associated with the condition.